Showing results (21-30 of 845) with videos related to
Sort By:
Pageof 85
Diabetes & Vascular Disease Research|September 13, 2014
The dual peroxisome proliferator-activated receptor alpha/delta agonist GFT505 exerts anti-diabetic effects in db/db mice without peroxisome proliferator-activated receptor gamma-associated adverse cardiac effectsRémy Hanf, Lesley J Millatt, Bertrand Cariou, et al.Transgenic Research|June 21, 2015
Screening strategy to generate cell specific recombination: a case report with the RIP-Cre miceValeria Spinelli, Céline Martin, Emilie Dorchies, et al.Archives of Physiology and Biochemistry|May 19, 2012
The human hepatocyte cell lines IHH and HepaRG: models to study glucose, lipid and lipoprotein metabolismCarolina Huaman Samanez, Sandrine Caron, Olivier Briand, et al.Proceedings of the National Academy of Sciences of the United States of America|April 21, 2009
PPARalpha blocks glucocorticoid receptor alpha-mediated transactivation but cooperates with the activated glucocorticoid receptor alpha for transrepression on NF-kappaBNadia Bougarne, Réjane Paumelle, Sandrine Caron, et al.Postgraduate Medicine|June 5, 2009
A review of bile acid sequestrants: potential mechanism(s) for glucose-lowering effects in type 2 diabetes mellitusBart StaelsCurrent Medical Research and Opinion|August 18, 2006
Metformin and pioglitazone: Effectively treating insulin resistanceBart StaelsThe American Journal of Medicine|May 21, 2017
Cardiovascular Protection by Sodium Glucose Cotransporter 2 Inhibitors: Potential MechanismsBart StaelsThe American Journal of Cardiology|June 14, 2017
Cardiovascular Protection by Sodium Glucose Cotransporter 2 Inhibitors: Potential MechanismsBart StaelsPageof 85